const EudraCTData = [
  {
    "EudraCT Number": "2008-006649-18",
    "Sponsor Protocol Number": "08/0214",
    "Sponsor Name": "University College London",
    "Full Title": "CMV TCR Gene Therapy: A Phase I Safety, Toxicity and Feasibility Study of Adoptive Immunotherapy with CMV TCR-transduced Donor-derived T cells for Recipients of Allogeneic Haematopoietic Stem Cell ...",
    "Start Date": "2011-11-16",
    "Medical condition": "CMV reactivation/infection in post allogeneic haematopoietic stem cell transplant recipients. Allo-HSCT being performed for underlying haematological malignancy (eg, AML, ALL, NHL, Hodgkin Lymphoma...",
    "Disease": "Version: 19.0, SOC Term: 100000004865, Classification Code: 10067859, Term: Allogenic stem cell transplantation, Level: LLT",
    "Population Age": "Adults",
    "Gender": "Male, Female",
    "Trial protocol": "GB(Prematurely Ended)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2008-006649-18"
  },
  {
    "EudraCT Number": "2008-002768-32",
    "Sponsor Protocol Number": "MM03",
    "Sponsor Name": "Freistaat Bayern",
    "Full Title": "A prospective phase I/II, one-arm, one-stage multi-center, open label study of lenalidomide in combination with pioglitazone, dexamethasone and metronomic low-dose chemotherapy with treosulfan in p...",
    "Start Date": "2009-06-08",
    "Medical condition": "Multiple myeloma",
    "Disease": "Version: 21.0, SOC Term: 100000004864, Classification Code: 10028228, Term: Multiple myeloma, Level: LLT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "DE(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2008-002768-32"
  },
  {
    "EudraCT Number": "2010-022400-53",
    "Sponsor Protocol Number": "NLH-01",
    "Sponsor Name": "Køge Hospital",
    "Full Title": "Intracoronary administration of melatonin for patients with acute myocardial infarction: a placebo controlled randomized study.",
    "Start Date": "2011-01-13",
    "Medical condition": "Acute Myocardial Infarction",
    "Disease": "Version: 18.1, SOC Term: 10007541 - Cardiac disorders, Classification Code: 10000891, Term: Acute myocardial infarction, Level: PT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "DK(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2010-022400-53"
  },
  {
    "EudraCT Number": "2008-003174-18",
    "Sponsor Protocol Number": "PACET-CUP",
    "Sponsor Name": "Universitätsklinikum Heidelberg",
    "Full Title": "Open-labeled, randomized multi-center phase II study evaluating the efficacy and safety of Paclitaxel/ Carboplatin with and without Cetuximab as first-line treatment of adeno- and undifferentiated ...",
    "Start Date": "2009-12-18",
    "Medical condition": "adeno- and undifferentiated Carcinoma of Unknown Primary (CUP)",
    "Disease": "",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "DE(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2008-003174-18"
  },
  {
    "EudraCT Number": "2006-001095-21",
    "Sponsor Protocol Number": "A5I16",
    "Sponsor Name": "Sanofi Pasteur Inc.",
    "Full Title": "Immunogenicity and Safety of PEDIACEL®, a Combined Diphtheria, Tetanus, Five Component Acellular Pertussis, Inactivated Poliomyelitis and Haemophilus influenzae Type b Conjugate Vaccine (Adsorbed),...",
    "Start Date": "2016-04-19",
    "Medical condition": "Pertussis, adsorbed diphtheria and tetanus toxoids, inactivated poliomyelitis and polysaccharide of H. influenza type b bound to tetanus toxoid",
    "Disease": "",
    "Population Age": "Infants and toddlers, Under 18",
    "Gender": "Male, Female",
    "Trial protocol": "Outside EU/EEA",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2006-001095-21"
  },
  {
    "EudraCT Number": "2006-000653-22",
    "Sponsor Protocol Number": "GART1013",
    "Sponsor Name": "Moorfields Eye Hospital",
    "Full Title": "The UK Glaucoma Treatment Study",
    "Start Date": "2006-07-26",
    "Medical condition": "Primary open-angle Glaucoma Pseudoexfoliation Glaucoma",
    "Disease": "Version: 20.0, SOC Term: 100000004853, Classification Code: 10037118, Term: Pseudoexfoliation glaucoma, Level: LLT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "GB(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2006-000653-22"
  },
  {
    "EudraCT Number": "2008-000581-23",
    "Sponsor Protocol Number": "CSPP100A2244",
    "Sponsor Name": "Novartis Pharma AG",
    "Full Title": "A randomized, double-masked, placebo-controlled add on study to assess the efficacy of oral aliskiren 300 mg once daily for diabetic macular edema",
    "Start Date": "2008-07-28",
    "Medical condition": "Diabetic Macular Edema (DME) in hypertensive patients",
    "Disease": "Version: 19.0, SOC Term: 100000004853, Classification Code: 10057915, Term: Diabetic macular oedema, Level: LLT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "DK(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2008-000581-23"
  },
  {
    "EudraCT Number": "2007-001058-16",
    "Sponsor Protocol Number": "V00147GL202",
    "Sponsor Name": "PIERRE FABRE MEDICAMENT",
    "Full Title": "A PHASE II DOUBLE-BLIND VEHICLE-CONTROLLED CROSSOVER SINGLE DOSE (400 µG) V0147 GEL EFFECT AND TOLERANCE STUDY IN SPINAL CORD INJURED PATIENTS WITH ERECTILE DYSFUNCTION",
    "Start Date": "2007-04-30",
    "Medical condition": "Erectile dysfunction",
    "Disease": "Version: 21.1, SOC Term: 10038604 - Reproductive system and breast disorders, Classification Code: 10052004, Term: Organic erectile dysfunction, Level: PT",
    "Population Age": "Adults",
    "Gender": "Male",
    "Trial protocol": "FR(Prematurely Ended)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2007-001058-16"
  },
  {
    "EudraCT Number": "2008-007225-39",
    "Sponsor Protocol Number": "CareRA",
    "Sponsor Name": "University Hospitals Leuven",
    "Full Title": "A 2 year prospective multicentre randomised controlled trial comparing effectiveness in daily practice of different treatment strategies for early RA",
    "Start Date": "2009-01-06",
    "Medical condition": "early active Rheumatoid Arthritis, previously untreated with DMARDS",
    "Disease": "Version: 20.0, SOC Term: 10028395 - Musculoskeletal and connective tissue disorders, Classification Code: 10039073, Term: Rheumatoid arthritis, Level: PT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "BE(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2008-007225-39"
  },
  {
    "EudraCT Number": "2010-023062-40",
    "Sponsor Protocol Number": "PRP-001",
    "Sponsor Name": "Medivation, Inc.",
    "Full Title": "A Phase 1/2, First in Human, Single-arm, Open-label Study of Once a Day, Orally Administered Talazoparib (BMN 673) in Patients with Advanced or Recurrent Solid Tumors",
    "Start Date": "2011-04-19",
    "Medical condition": "Advanced or recurrent solid tumors for which there is no accepted standard treatment or for which standard treatment has failed.  Patients may also be eligible if they are unable or decline to unde...",
    "Disease": "Version: 19.0, SOC Term: 100000004864, Classification Code: 10065147, Term: Malignant solid tumor, Level: LLT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "GB(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2010-023062-40"
  },
  {
    "EudraCT Number": "2009-016877-14",
    "Sponsor Protocol Number": "H1N1-2009",
    "Sponsor Name": "COPSAC",
    "Full Title": "H1N1v Vaccination of Pregnant Women: A Longitudinal Cohort Study Characterizing Influenza A-H1N1v Vaccination in Pregnant Women",
    "Start Date": "2009-11-04",
    "Medical condition": "Protection against Influenza A H1N1v disease",
    "Disease": "",
    "Population Age": "In utero, Preterm newborn infants, Newborns, Infants and toddlers, Under 18, Adults",
    "Gender": "Male, Female",
    "Trial protocol": "DK(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2009-016877-14"
  },
  {
    "EudraCT Number": "2011-002044-28",
    "Sponsor Protocol Number": "HGT-MLD-070",
    "Sponsor Name": "Shire Human Genetics Therapies Inc",
    "Full Title": "A Phase I/II, Multicenter, Open-label, Dose Escalation Study of HGT-1110 Administered Intrathecally in Children with Metachromatic Leukodystrophy",
    "Start Date": "2012-06-14",
    "Medical condition": "Treatment of Metachromatic Leukodystrophy",
    "Disease": "Version: 19.0, SOC Term: 10010331 - Congenital, familial and genetic disorders, Classification Code: 10067609, Term: Metachromatic leukodystrophy, Level: PT",
    "Population Age": "Infants and toddlers, Children, Under 18",
    "Gender": "Male, Female",
    "Trial protocol": "DE(Completed) DK(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2011-002044-28"
  },
  {
    "EudraCT Number": "2013-001048-73",
    "Sponsor Protocol Number": "BAY41-6551/13084",
    "Sponsor Name": "Bayer AG",
    "Full Title": "A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of BAY 41-6551 as Adjunctive Therapy in Intubated and Mechanically-Ventilated Pati...",
    "Start Date": "2013-07-25",
    "Medical condition": "Gram-negative pneumonia",
    "Disease": "Version: 19.0, SOC Term: 100000004862, Classification Code: 10035701, Term: Pneumonia gram-negative bacterial NOS, Level: LLT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "CZ(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-001048-73"
  },
  {
    "EudraCT Number": "2012-001650-26",
    "Sponsor Protocol Number": "AnticholiumperSeIII",
    "Sponsor Name": "Ruprecht-Karls-University Heidelberg, Med Faculty represented by Universitätsklinikum Heidelberg and its Commercial D",
    "Full Title": "A randomised, placebo-controlled, double-blind, monocentre study on the application of physostigminsalicylate (Anticholium®) as adjunctive measure in perioperative sepsis/septic shock",
    "Start Date": "2014-04-28",
    "Medical condition": "",
    "Disease": "Version: 19.0, SOC Term: 10021881 - Infections and infestations, Classification Code: 10040047, Term: Sepsis, Level: PT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "DE(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-001650-26"
  },
  {
    "EudraCT Number": "2012-000447-27",
    "Sponsor Protocol Number": "USKH_VL1",
    "Sponsor Name": "Universitätsklinikum Schleswig-Holstein, Campus Kiel",
    "Full Title": "Open Label Study for the Functional Characterization of Drug Metabolism and Transport in patients before routine visceral surgery",
    "Start Date": "2012-07-25",
    "Medical condition": "Pharmacokinetic trial in patients, with a good general condition before standard abdominal surgery",
    "Disease": "",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "DE(Temporarily Halted)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-000447-27"
  },
  {
    "EudraCT Number": "2011-005066-38",
    "Sponsor Protocol Number": "CINC424AGB02",
    "Sponsor Name": "Novartis Pharmaceuticals UK Ltd",
    "Full Title": "A UK open-label, multicentre, exploratory Phase II study of INC424 for patients with primary myelofibrosis (PMF) or post polycythemia myelofibrosis (PPV MF) or post-essential thrombocythemia myelof...",
    "Start Date": "2012-03-09",
    "Medical condition": "primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (PPV MF) or Post essential thrombocythemia myelofibrosis (PET-MF)",
    "Disease": "",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "GB(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2011-005066-38"
  },
  {
    "EudraCT Number": "2011-005082-21",
    "Sponsor Protocol Number": "Uni-Koeln-1491",
    "Sponsor Name": "University of Cologne",
    "Full Title": "Targeted BEACOPP variants in patients with newly diagnosed advanced classical Hodgkin Lymphoma",
    "Start Date": "2012-09-25",
    "Medical condition": "newly diagnosed advanced classical Hodgkin Lymphoma",
    "Disease": "Version: 20.0, SOC Term:  100000004851, Classification Code: 10025319, Term: Lymphomas Hodgkin's disease, Level: HLGT",
    "Population Age": "Adults",
    "Gender": "Male, Female",
    "Trial protocol": "DE(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2011-005082-21"
  },
  {
    "EudraCT Number": "2012-004439-22",
    "Sponsor Protocol Number": "CAIN457F2312",
    "Sponsor Name": "Novartis Pharma Services AG",
    "Full Title": "A Phase III randomized, double-blind, placebo-controlled multicenter study of subcutaneous secukinumab in prefilled syringes to demonstrate the efficacy at 24 weeks and to assess the long term effi...",
    "Start Date": "2013-04-08",
    "Medical condition": "Psoriatic arthritis",
    "Disease": "Version: 19.1, SOC Term: 100000004859, Classification Code: 10037160, Term: Psoriatic arthritis, Level: LLT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "GB(Completed) BE(Completed) CZ(Completed) DE(Completed) PL(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-004439-22"
  },
  {
    "EudraCT Number": "2012-002786-35",
    "Sponsor Protocol Number": "12/0246",
    "Sponsor Name": "University College London",
    "Full Title": "A randomised double-blind controlled phase III study to compare the efficacy and safety of intravenous ferric carboxymaltose with placebo in patients with anaemia undergoing major open abdominal su...",
    "Start Date": "2012-11-05",
    "Medical condition": "Anaemia",
    "Disease": "Version: 19.0, SOC Term: 10005329 - Blood and lymphatic system disorders, Classification Code: 10022972, Term: Iron deficiency anaemia, Level: PT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "GB(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-002786-35"
  },
  {
    "EudraCT Number": "2012-005629-65",
    "Sponsor Protocol Number": "RG_12-269",
    "Sponsor Name": "University of Birmingham",
    "Full Title": "Management of Transformed Chronic myeloid leukaemia: Ponatinib and Intensive chemotherapy: a dose finding study",
    "Start Date": "2014-01-15",
    "Medical condition": "Chronic Myeloid Leukaemia (CML) in Blast Phase",
    "Disease": "Version: 20.1, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10009013, Term: Chronic myeloid leukaemia, Level: PT",
    "Population Age": "Adolescents, Under 18, Adults",
    "Gender": "Male, Female",
    "Trial protocol": "GB(GB - no longer in EU/EEA)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-005629-65"
  },
  {
    "EudraCT Number": "2012-003741-15",
    "Sponsor Protocol Number": "MSC_apceth_101/1",
    "Sponsor Name": "apceth GmbH & Co. KG",
    "Full Title": "Treatment of Advanced Gastrointestinal Cancer in a Phase I/II trial with modified autologous MSC_apceth_101. Open-label, multicentre, phase I/II.",
    "Start Date": "2013-06-27",
    "Medical condition": "Patients suffering from advanced, recurrent or metastatic gastrointestinal adenocarcinoma.",
    "Disease": "Version: 18.1, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10017991, Term: Gastrointestinal neoplasms malignant and unspecified, Level: HLGT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "DE(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-003741-15"
  },
  {
    "EudraCT Number": "2011-001795-19",
    "Sponsor Protocol Number": "Uni-Koeln-1341",
    "Sponsor Name": "University of Cologne",
    "Full Title": "STATIN RECAPTURE THERAPY BEFORE CORONARY ARTERY BYPASS GRAFTING  (ACRONYM: START-CABG TRIAL)",
    "Start Date": "2012-09-13",
    "Medical condition": "Patients on a long term statin therapy with established coronary artery disease (CAD) scheduled for isolated surgical myocardial revascularisation (i.e. CABG)",
    "Disease": "",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "DE(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2011-001795-19"
  },
  {
    "EudraCT Number": "2012-000309-60",
    "Sponsor Protocol Number": "120101",
    "Sponsor Name": "Göteborgs universitet",
    "Full Title": "Biochemical and neuropsychological effects on Premenstrual Dysphoric Disorder after acute administration of escitalopram",
    "Start Date": "2016-03-30",
    "Medical condition": "Premenstrual Dysphoric Disorder",
    "Disease": "Version: 18.1, SOC Term: 10038604 - Reproductive system and breast disorders, Classification Code: 10051537, Term: Premenstrual dysphoric disorder, Level: PT",
    "Population Age": "Adults",
    "Gender": "Female",
    "Trial protocol": "SE(Ongoing)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-000309-60"
  },
  {
    "EudraCT Number": "2013-001722-25",
    "Sponsor Protocol Number": "ZonMw80-83600-98-10226",
    "Sponsor Name": "VU University Medical Center",
    "Full Title": "Cholinesterase inhibitors to slow progression of visual hallucinations in Parkinson’s disease: a multi-center placebo-controlled trial (CHEVAL)",
    "Start Date": "2013-08-27",
    "Medical condition": "Parkinson's disease",
    "Disease": "Version: 18.0, SOC Term: 10029205 - Nervous system disorders, Classification Code: 10061536, Term: Parkinson's disease, Level: PT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "NL(Prematurely Ended)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-001722-25"
  },
  {
    "EudraCT Number": "2012-001144-22",
    "Sponsor Protocol Number": "ML28337",
    "Sponsor Name": "ROCHE SAS",
    "Full Title": "A RANDOMIZED, OPEN-LABEL, PHASE II STUDY ASSESSING THE EFFICACY AND THE SAFETY OF BEVACIZUMAB IN NEOADJUVANT THERAPY IN PATIENTS WITH FIGO STAGE IIIC/IV OVARIAN, TUBAL OR PERITONEAL ADENOCARCINOMA,...",
    "Start Date": "2012-07-03",
    "Medical condition": "Epithelial ovarian cancer",
    "Disease": "Version: 20.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10033128, Term: Ovarian cancer, Level: PT",
    "Population Age": "Adults, Elderly",
    "Gender": "Female",
    "Trial protocol": "FR(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-001144-22"
  },
  {
    "EudraCT Number": "2011-004368-31",
    "Sponsor Protocol Number": "I1F-MC-RHBC",
    "Sponsor Name": "Eli Lilly and Company",
    "Full Title": "A 12-Week Multicenter, Randomized, Double-Blind, Placebo Controlled Study Comparing the Efficacy and Safety of LY2439821 to Etanercept and Placebo in Patients with Moderate to Severe Plaque Psorias...",
    "Start Date": "2012-09-13",
    "Medical condition": "Moderate to severe plaque psoriasis",
    "Disease": "Version: 18.1, SOC Term: 100000004858, Classification Code: 10071117, Term: Plaque psoriasis, Level: LLT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "HU(Completed) DE(Completed) BG(Completed) PL(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2011-004368-31"
  },
  {
    "EudraCT Number": "2011-005279-18",
    "Sponsor Protocol Number": "RG_11-164",
    "Sponsor Name": "University of Birmingham",
    "Full Title": "A RandoMised study of best Available therapy versus JAK Inhibition in patients with high risk Polycythaemia Vera or Essential Thrombocythaemia who are resistant or intolerant to HydroxyCarbamide.",
    "Start Date": "2012-02-08",
    "Medical condition": "Polycythaemia vera",
    "Disease": "Version: 19.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10015493, Term: Essential thrombocythaemia, Level: PT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "GB(GB - no longer in EU/EEA)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2011-005279-18"
  },
  {
    "EudraCT Number": "2009-014922-40",
    "Sponsor Protocol Number": "PT-171-503",
    "Sponsor Name": "Erasmus MC",
    "Full Title": "Carfilzomib in combination with Thalidomide and Dexamethasone for remission induction and consolidation of Multiple Myeloma at first presentation",
    "Start Date": "2010-07-07",
    "Medical condition": "Multiple myeloma at first presentation",
    "Disease": "",
    "Population Age": "Adults",
    "Gender": "Male, Female",
    "Trial protocol": "NL(Ongoing)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2009-014922-40"
  },
  {
    "EudraCT Number": "2011-004187-30",
    "Sponsor Protocol Number": "CO17730",
    "Sponsor Name": "Avraham Pharmaceuticals Ltd.",
    "Full Title": "A 36-month, multi-centre, randomized double-blind placebo-controlled study to evaluate the safety and efficacy of low dose Ladostigil in patients with Mild Cognitive Impairment (MCI)",
    "Start Date": "2011-12-14",
    "Medical condition": "Patient with Mild Cognitive Impairment",
    "Disease": "Version: 19.0, SOC Term: 100000004852, Classification Code: 10009846, Term: Cognitive impairment, Level: LLT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "AT(Completed) DE(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2011-004187-30"
  },
  {
    "EudraCT Number": "2013-003785-14",
    "Sponsor Protocol Number": "200249",
    "Sponsor Name": "Novartis Pharma Services AG",
    "Full Title": "A Phase I/II Study to Assess the Safety and Efficacy of Pazopanib and MK-3475 in Subjects with Advanced Renal Cell Carcinoma",
    "Start Date": "2014-03-03",
    "Medical condition": "Renal Cell Carcinoma",
    "Disease": "Version: 20.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10050513, Term: Metastatic renal cell carcinoma, Level: PT",
    "Population Age": "Adults",
    "Gender": "Male, Female",
    "Trial protocol": "GB(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-003785-14"
  },
  {
    "EudraCT Number": "2013-002505-62",
    "Sponsor Protocol Number": "STH16404",
    "Sponsor Name": "Sheffield Teaching Hospitals NHS Foundation Trust",
    "Full Title": "SarCaBon: A randomised phase II trial of Saracatinib versus placebo for cancer-induced bone pain",
    "Start Date": "2013-11-14",
    "Medical condition": "Cancer-induced bone pain",
    "Disease": "Version: 19.0, SOC Term: 100000004864, Classification Code: 10049038, Term: Metastatic bone pain, Level: LLT",
    "Population Age": "Adolescents, Under 18, Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "GB(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-002505-62"
  },
  {
    "EudraCT Number": "2013-003481-14",
    "Sponsor Protocol Number": "3004",
    "Sponsor Name": "National Institute of Diabetes and Digestive and Kidney Diseases",
    "Full Title": "Study of allopurinol to prevent GFR loss in type 1 diabetes",
    "Start Date": "2014-03-07",
    "Medical condition": "Type 1 diabetes, microalbuminuria or macroalbuminuria and mildly impaired kidney function.",
    "Disease": "Version: 19.1, SOC Term: 100000004848, Classification Code: 10037827, Term: Raised serum uric acid, Level: LLT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "DK(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-003481-14"
  },
  {
    "EudraCT Number": "2013-003488-71",
    "Sponsor Protocol Number": "OVG-2013/04",
    "Sponsor Name": "University of Oxford",
    "Full Title": "A pilot study of the impact of BCG administration on the immunogenicity of serogroup C meningococcal conjugate vaccine in healthy infants",
    "Start Date": "2013-12-12",
    "Medical condition": "Vaccine responses",
    "Disease": "",
    "Population Age": "Newborns, Infants and toddlers, Under 18",
    "Gender": "Male, Female",
    "Trial protocol": "GB(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-003488-71"
  },
  {
    "EudraCT Number": "2013-004108-20",
    "Sponsor Protocol Number": "UMCN-AKF13.05",
    "Sponsor Name": "Radboud University Nijmegen Medical Centre",
    "Full Title": "Improving the tolerability of the oral targeted anti-cancer drug pazopanib by food intake (DIET)",
    "Start Date": "2014-03-17",
    "Medical condition": "Patients  who are treated or will be treated with pazopanib.",
    "Disease": "Version: 19.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10073145, Term: Soft tissue cancer, Level: LLT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "NL(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-004108-20"
  },
  {
    "EudraCT Number": "2010-020841-29",
    "Sponsor Protocol Number": "ADAPT",
    "Sponsor Name": "King`s College London",
    "Full Title": "The role of anti-IgE (omalizumab) in the management of severe recalcitrant paediatric atopic eczema",
    "Start Date": "2011-07-07",
    "Medical condition": "Severe eczema in children",
    "Disease": "Version: 19.0, SOC Term: 100000004858, Classification Code: 10014189, Term: Eczema allergic atopic, Level: LLT",
    "Population Age": "Children, Adolescents, Under 18, Adults",
    "Gender": "Male, Female",
    "Trial protocol": "GB(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2010-020841-29"
  },
  {
    "EudraCT Number": "2011-004735-32",
    "Sponsor Protocol Number": "SP001",
    "Sponsor Name": "SOTIO a.s.",
    "Full Title": "Randomized, open-label, parallel-group, multi-centre phase II clinical trial with active cellular immunotherapy DCVAC/PCa  in patients with castrate-resistant prostate cancer",
    "Start Date": "2012-01-11",
    "Medical condition": "metastatic castrate-resistant prostate cancer",
    "Disease": "Version: 19.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10036909, Term: Prostate cancer metastatic, Level: PT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male",
    "Trial protocol": "CZ(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2011-004735-32"
  },
  {
    "EudraCT Number": "2010-023878-40",
    "Sponsor Protocol Number": "2.3",
    "Sponsor Name": "Medical University Vienna",
    "Full Title": "Influence of intra-arterial cerebral Papaverine Hydrochloride on cerebral glucose, lactate, pyruvate, glycerol, and glutamate concentrations, cerebral oxygenation, angiographic vasospasm, delayed s...",
    "Start Date": "2011-12-22",
    "Medical condition": "To demonstrate the influence of intra-arterial cerebral Papaverine Hydrochloride on cerebral glucose, lactate, pyruvate, glycerol, and glutamate concentrations and cerebral oxygenation in patients ...",
    "Disease": "",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "AT(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2010-023878-40"
  },
  {
    "EudraCT Number": "2011-003254-90",
    "Sponsor Protocol Number": "CLFG316A2204",
    "Sponsor Name": "Novartis Pharma Services AG",
    "Full Title": "A randomised, active-controlled, open-label, multiple-dose, proof-of-concept study of intravitreal LFG316 in patients with active non-infectious intermediate-, posterior-, or panuveitis requiring s...",
    "Start Date": "2012-05-14",
    "Medical condition": "Active non-infectious intermediate-, posterior-, or panuveitis requiring systemic immunosuppressive therapy",
    "Disease": "Version: 20.0, SOC Term:  100000014975, Classification Code: 10066681, Term: Acute uveitis, Level: LLT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "GB(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2011-003254-90"
  },
  {
    "EudraCT Number": "2012-003023-38",
    "Sponsor Protocol Number": "GERMAIN",
    "Sponsor Name": "Friedrich-Schiller-Universität Jena",
    "Full Title": "Phase II study of Bortezomib, Melphalan, Prednisone (VMP) followed by Lenalidomide maintenance vs. VMP without maintenance in Myeloma patients not eligible to high-dose chemotherapy and autologous ...",
    "Start Date": "2013-10-30",
    "Medical condition": "multiple myeloma",
    "Disease": "Version: 19.0, SOC Term: 100000004864, Classification Code: 10028228, Term: Multiple myeloma, Level: LLT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "DE(Prematurely Ended)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-003023-38"
  },
  {
    "EudraCT Number": "2012-000756-34",
    "Sponsor Protocol Number": "2012.001",
    "Sponsor Name": "NeuroVive Pharmaceutical AB",
    "Full Title": "Copenhagen Head Injury Ciclosporin (CHIC) Study:  An open-label, uncontrolled Phase II -study to investigate pharmacokinetics, safety and biomarkers of effectiveness of NeuroSTAT® (ciclosporin) i...",
    "Start Date": "2012-11-02",
    "Medical condition": "Severe Traumatic Brain Injury",
    "Disease": "",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "DK(Prematurely Ended)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-000756-34"
  },
  {
    "EudraCT Number": "2013-003301-26",
    "Sponsor Protocol Number": "IAFIPF001",
    "Sponsor Name": "Newcastle Upon Tyne Hospitals NHS Foundation Trust",
    "Full Title": "A randomised placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis (IPF)",
    "Start Date": "2013-09-20",
    "Medical condition": "Idiopathic Pulmonary Fibrosis (IPF)",
    "Disease": "Version: 19.0, SOC Term: 10038738 - Respiratory, thoracic and mediastinal disorders, Classification Code: 10021240, Term: Idiopathic pulmonary fibrosis, Level: PT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "GB(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-003301-26"
  },
  {
    "EudraCT Number": "2014-003644-12",
    "Sponsor Protocol Number": "2014-003644-12",
    "Sponsor Name": "Neuromuscular Research Unit, Rigshospitalet",
    "Full Title": "The effect of Triheptanoin in adults with McArdle Disease (Glycogen Storage Disease Type V)",
    "Start Date": "2015-02-20",
    "Medical condition": "McArdle Disease",
    "Also called": "Glycogen Storage Disease Type V or Myophosphorylase Deficiency",
    "Disease": "Version: 19.0, SOC Term: 10010331 - Congenital, familial and genetic disorders, Classification Code: 10018462, Term: Glycogen storage disease type V, Level: PT",
    "Population Age": "Adults",
    "Gender": "Male, Female",
    "Trial protocol": "DK(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-003644-12"
  },
  {
    "EudraCT Number": "2017-000494-36",
    "Sponsor Protocol Number": "AC-083-103",
    "Sponsor Name": "Idorsia Pharmaceuticals Ltd",
    "Full Title": "A Phase 2a, multi-center, single-blind, within-subject, placebo-controlled study to assess the pharmacodynamics of ACT-709478 in subjects with photosensitive epilepsy",
    "Start Date": "2017-07-26",
    "Medical condition": "Photosensitive epilepsy",
    "Disease": "",
    "Population Age": "Adults",
    "Gender": "Male, Female",
    "Trial protocol": "DE(Completed) FR(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000494-36"
  },
  {
    "EudraCT Number": "2014-003503-29",
    "Sponsor Protocol Number": "D5553C00003",
    "Sponsor Name": "AstraZeneca AB",
    "Full Title": "A 28-week, Multicenter, Randomized, Double-Blind, Active-Controlled, Phase 3 Study with a 24-week Extension Phase Followed by a 52-week Extension Phase to Evaluate the Efficacy and Safety of Simult...",
    "Start Date": "2014-12-16",
    "Medical condition": "Diabetes Mellitus",
    "Disease": "Version: 20.0, SOC Term: 100000004860, Classification Code: 10012602, Term: Diabetes mellitus (incl subtypes), Level: HLT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "SK(Completed) HU(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-003503-29"
  },
  {
    "EudraCT Number": "2014-004909-33",
    "Sponsor Protocol Number": "LCTU122",
    "Sponsor Name": "Manchester University NHS Foundation Trust",
    "Full Title": "Thrombin Inhibition Preoperatively in Early Breast Cancer",
    "Start Date": "2015-09-21",
    "Medical condition": "Breast Cancer",
    "Disease": "Version: 20.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10057654, Term: Breast cancer female, Level: PT",
    "Population Age": "Adults, Elderly",
    "Gender": "Female",
    "Trial protocol": "GB(GB - no longer in EU/EEA)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-004909-33"
  },
  {
    "EudraCT Number": "2015-005406-11",
    "Sponsor Protocol Number": "D1683C00005",
    "Sponsor Name": "Astrazeneca AB",
    "Full Title": "A Multi-Center, Randomized, Double-Blind, Active-Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Saxagliptin 5mg Co-administered with Dapagliflozin 5mg compared t...",
    "Start Date": "2016-05-25",
    "Medical condition": "Type 2 diabetes mellitus, inadequate glycaemic control",
    "Disease": "",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "DE(Completed) CZ(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005406-11"
  },
  {
    "EudraCT Number": "2013-005543-90",
    "Sponsor Protocol Number": "20130108",
    "Sponsor Name": "Amgen Inc",
    "Full Title": "A Randomized, Double-Blind Study to Compare Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of ABP 798 With Rituximab in Subjects With Moderate to Severe Rheumatoid Arthritis",
    "Start Date": "2014-08-26",
    "Medical condition": "Rheumatoid arthritis",
    "Disease": "Version: 20.0, SOC Term: 10028395 - Musculoskeletal and connective tissue disorders, Classification Code: 10039073, Term: Rheumatoid arthritis, Level: PT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "HU(Completed) DE(Completed) PL(Completed) BG(Completed) EE(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-005543-90"
  },
  {
    "EudraCT Number": "2016-000376-26",
    "Sponsor Protocol Number": "ZPL521/101",
    "Sponsor Name": "Ziarco Pharma Ltd",
    "Full Title": "A Randomised, Adaptive Design, Double-Blind (3rd Party Open), Placebo Controlled, Sequential Group Study to  Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Applica...",
    "Start Date": "2016-05-09",
    "Medical condition": "Atopic Dermatitis",
    "Disease": "Version: 18.1, SOC Term: 100000004858, Classification Code: 10003639, Term: Atopic dermatitis, Level: LLT",
    "Population Age": "Adults",
    "Gender": "Male, Female",
    "Trial protocol": "GB(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-000376-26"
  },
  {
    "EudraCT Number": "2017-002449-31",
    "Sponsor Protocol Number": "ZP4207-16137",
    "Sponsor Name": "Zealand Pharma A/S",
    "Full Title": "A phase 3, randomized, double-blind, parallel trial to confirm the clinical efficacy and safety of dasiglucagon in the rescue treatment of hypoglycemia in subjects with type 1 diabetes mellitus (T1...",
    "Start Date": "2018-02-16",
    "Medical condition": "Type 1 diabetes mellitus",
    "Disease": "Version: 20.0, SOC Term: 10027433 - Metabolism and nutrition disorders, Classification Code: 10027433, Term: Metabolism and nutrition disorders, Level: SOC",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "DE(Completed) AT(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-002449-31"
  },
  {
    "EudraCT Number": "2020-001109-22",
    "Sponsor Protocol Number": "PBGM01-001",
    "Sponsor Name": "Passage Bio, Inc.",
    "Full Title": "A Phase 1/2 Open-Label, Multicenter, Dose Ranging and Confirmatory Study to Assess the Safety, Tolerability and Efficacy of a Single Dose of PBGM01 Delivered into the Cisterna Magna of Pediatric Su...",
    "Start Date": "Information not available in EudraCT",
    "Medical condition": "GM1 gangliosidosis (GM1) is an autosomal recessive disorder that results from mutations in the human galactosidase beta 1 gene (GLB1), which encodes beta-galactosidase (β-gal).",
    "Disease": "",
    "Population Age": "Infants and toddlers, Under 18",
    "Gender": "Male, Female",
    "Trial protocol": "GB(GB - no longer in EU/EEA)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001109-22"
  },
  {
    "EudraCT Number": "2015-005674-37",
    "Sponsor Protocol Number": "COL-MIG-305(H8H-CD-LAHL)",
    "Sponsor Name": "Eli Lilly and Company",
    "Full Title": "An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR)",
    "Start Date": "2016-11-01",
    "Medical condition": "acute migraine",
    "Disease": "Version: 20.0, SOC Term: 10029205 - Nervous system disorders, Classification Code: 10027607, Term: Migraine with aura, Level: PT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "GB(Completed) DE(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-005674-37"
  },
  {
    "EudraCT Number": "2016-000593-38",
    "Sponsor Protocol Number": "MR308-3502",
    "Sponsor Name": "Mundipharma Research GmbH & Co. KG",
    "Full Title": "A Randomized, Double-Blind, Multicenter, Placebo- and active Comparator-Controlled Study to evaluate Efficacy and Safety of MR308 in the Treatment of Acute Pain After Abdominal Hysterectomy Surgery...",
    "Start Date": "2016-12-05",
    "Medical condition": "Acute pain after open total or subtotal abdominal hysterectomy",
    "Disease": "Version: 19.0, SOC Term: 100000004867, Classification Code: 10066714, Term: Acute pain, Level: LLT",
    "Population Age": "Adults",
    "Gender": "Female",
    "Trial protocol": "ES(Completed) SK(Completed) LV(Completed) PL(Completed) BG(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-000593-38"
  },
  {
    "EudraCT Number": "2013-004615-45",
    "Sponsor Protocol Number": "BPR-PIP-002",
    "Sponsor Name": "Basilea Pharmaceutica International Ltd",
    "Full Title": "A multicentre, randomized, investigator-blind, active-controlled study to evaluate the safety, tolerability, pharmacokinetics and efficacy of ceftobiprole versus intravenous standard-of-care cephal...",
    "Start Date": "2016-12-02",
    "Medical condition": "Hospital-acquired pneumonia or community-acquired pneumonia requiring hospitalisation.",
    "Disease": "Version: 19.0, SOC Term: 100000004862, Classification Code: 10052596, Term: Nosocomial pneumonia, Level: LLT",
    "Population Age": "Infants and toddlers, Children, Adolescents, Under 18",
    "Gender": "Male, Female",
    "Trial protocol": "HU(Completed) BG(Completed) Outside EU/EEA",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2013-004615-45"
  },
  {
    "EudraCT Number": "2017-001351-31",
    "Sponsor Protocol Number": "ED17/93260",
    "Sponsor Name": "University of Leeds",
    "Full Title": "A double-blind, randomized, placebo-controlled phase II pilot trial investigating efficacy, safety and feasibility of 11β-hydroxysteroid dehydrogenase type 1 inhibition by AZD4017 to improve skin f...",
    "Start Date": "2017-09-04",
    "Medical condition": "Type 2 diabetes",
    "Disease": "Version: 20.0, SOC Term: 10027433 - Metabolism and nutrition disorders, Classification Code: 10067585, Term: Type 2 diabetes mellitus, Level: PT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "GB(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-001351-31"
  },
  {
    "EudraCT Number": "2017-000724-10",
    "Sponsor Protocol Number": "60978",
    "Sponsor Name": "Academic Medical Center",
    "Full Title": "Targeting esophageal cancer with HDL nanoparticles: an imaging study",
    "Start Date": "2018-07-04",
    "Medical condition": "Primary esophageal cancer",
    "Disease": "",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "NL(Ongoing)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000724-10"
  },
  {
    "EudraCT Number": "2016-001223-31",
    "Sponsor Protocol Number": "KAISII",
    "Sponsor Name": "King's College Hospital NHS Foundation Trust",
    "Full Title": "Incidence of Invasive Fungal Disease in Patients receiving Immunosuppressive Therapy, Intensive Chemotherapy or Reduced Intensity Haematopoietic Stem Cell Transplantation on Posaconazole Prophylaxis",
    "Start Date": "2016-10-11",
    "Medical condition": "Aplastic Anaemia, Myelodysplastic syndromes, Acute Myeloid Leukaemia undergoing immunosuppression therapy, high dose chemotherapy or reduced intensity stem cell transplantation",
    "Disease": "Version: 19.0, SOC Term: 10005329 - Blood and lymphatic system disorders, Classification Code: 10002967, Term: Aplastic anaemia, Level: PT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "GB(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001223-31"
  },
  {
    "EudraCT Number": "2016-001853-41",
    "Sponsor Protocol Number": "57698",
    "Sponsor Name": "Academic Medical Center",
    "Full Title": "Intensive endoscopic therapy versus conventional treatment for untreated benign anastomotic strictures after esophagectomy: a pilot and randomized controlled trial",
    "Start Date": "2018-09-19",
    "Medical condition": "Benign esophagogastric anastomotic strictures after esophagectomy",
    "Disease": "Version: 20.0, SOC Term: 10042613 - Surgical and medical procedures, Classification Code: 10015460, Term: Esophagectomy, Level: LLT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "NL(Prematurely Ended)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001853-41"
  },
  {
    "EudraCT Number": "2014-002209-39",
    "Sponsor Protocol Number": "M14LTK",
    "Sponsor Name": "The Netherlands Cancer Institute",
    "Full Title": "Phase I/II study with lapatinib plus trametinib in patients with metastatic KRAS mutant non-small cell lungcancer",
    "Start Date": "2014-07-30",
    "Medical condition": "non-small cell lung cancer",
    "Disease": "",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "NL(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-002209-39"
  },
  {
    "EudraCT Number": "2016-004529-17",
    "Sponsor Protocol Number": "YO39609",
    "Sponsor Name": "F. Hoffman-La Roche Ltd",
    "Full Title": "A PHASE Ib/II, OPEN-LABEL, MULTICENTER, RANDOMIZED, UMBRELLA STUDY EVALUATING THE EFFICACY AND SAFETY OF MULTIPLE IMMUNOTHERAPY-BASED TREATMENT COMBINATIONS IN PATIENTS WITH LOCALLY ADVANCED UNRESE...",
    "Start Date": "2018-07-17",
    "Medical condition": "Locally advanced unresectable or Metastatic gastric or gastroesophageal junction cancer or esophageal cancer",
    "Disease": "Version: 21.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10030151, Term: Oesophageal cancer, Level: LLT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "GB(GB - no longer in EU/EEA) ES(Prematurely Ended)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-004529-17"
  },
  {
    "EudraCT Number": "2015-004898-32",
    "Sponsor Protocol Number": "SAM103848",
    "Sponsor Name": "GlaxoSmithKline Research & Development Ltd.",
    "Full Title": "Pediatric Asthma Clinical Effectiveness study (PEACE). A Randomized, Double-Blind, Double Dummy, Parallel Group comparative clinical study of Salmeterol/Fluticasone propionate Inhalation Powder (50...",
    "Start Date": "2016-12-08",
    "Medical condition": "Asthma",
    "Disease": "",
    "Population Age": "Children, Adolescents, Under 18",
    "Gender": "Male, Female",
    "Trial protocol": "Outside EU/EEA",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-004898-32"
  },
  {
    "EudraCT Number": "2016-005083-34",
    "Sponsor Protocol Number": "CAPI2017NL10",
    "Sponsor Name": "University Medical Center Utrecht",
    "Full Title": "Conestat alfa as prophylactic treatment for idiopathic non-histaminergic acquired angioedema",
    "Start Date": "2017-08-23",
    "Medical condition": "The medical condition to be investigated is idiopathic non-histaminergic angioedema (InH-AAE). This disease is characterized by recurrent episodes with swelling of the subcutis and mucous membranes...",
    "Disease": "",
    "Population Age": "Adults",
    "Gender": "Male, Female",
    "Trial protocol": "NL(Ongoing)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-005083-34"
  },
  {
    "EudraCT Number": "2015-002416-33",
    "Sponsor Protocol Number": "GLARGL07667",
    "Sponsor Name": "sanofi-aventis France",
    "Full Title": "An interventional, Open-label, single-arm, multicenter, 24 Weeks phase 4 study assessing the Efficacy and Safety of  Toujeo in patients with Type  2 Diabetes inadequately controlled with Basal Insulin",
    "Start Date": "2016-02-15",
    "Medical condition": "Type 2 diabetes mellitus",
    "Disease": "Version: 19.0, SOC Term: 10027433 - Metabolism and nutrition disorders, Classification Code: 10067585, Term: Type 2 diabetes mellitus, Level: PT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "FR(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-002416-33"
  },
  {
    "EudraCT Number": "2016-002691-27",
    "Sponsor Protocol Number": "690550",
    "Sponsor Name": "Academic Medical Center",
    "Full Title": "An open label exploratory analysis of the histological,  immunological and microbiome changes of the colonic mucosa during treatment with tofacitinib for moderate-severe ulcerative colitis",
    "Start Date": "2017-10-19",
    "Medical condition": "Ulcerative colitis",
    "Disease": "Version: 20.0, SOC Term: 100000004856, Classification Code: 10045365, Term: Ulcerative colitis, Level: LLT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "NL(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-002691-27"
  },
  {
    "EudraCT Number": "2017-003029-14",
    "Sponsor Protocol Number": "D9480C00006",
    "Sponsor Name": "AstraZeneca AB",
    "Full Title": "A phase 3b, multicenter, prospective, randomized, double blind, placebocontrolled study to reduce incidence of pre-dialysis hyperkalemia with Sodium Zirconium Cyclosilicate (DIALIZE)",
    "Start Date": "2018-02-09",
    "Medical condition": "Hyperkalemia among patients on stable hemodialysis (pre-dialysis serum K >5.4 mmol/L after long inter-dialytic interval and >5.0 mmol/L after one short inter-dialytic interval)",
    "Disease": "Version: 20.1, SOC Term: 10027433 - Metabolism and nutrition disorders, Classification Code: 10020646, Term: Hyperkalaemia, Level: PT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "GB(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-003029-14"
  },
  {
    "EudraCT Number": "2016-001440-18",
    "Sponsor Protocol Number": "IACI2016",
    "Sponsor Name": "university medical center utrecht",
    "Full Title": "Pharmacokinetic interactions between ivacaftor and cytochrome P450 3A4 inhibitors in cystic fibrosis patients and healthy controls",
    "Start Date": "2018-05-30",
    "Medical condition": "cystic fibrosis and healthy subjects",
    "Disease": "",
    "Population Age": "Adults",
    "Gender": "Male, Female",
    "Trial protocol": "NL(Ongoing)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001440-18"
  },
  {
    "EudraCT Number": "2018-004202-25",
    "Sponsor Protocol Number": "PI18/01297",
    "Sponsor Name": "Luis Nombela Franco",
    "Full Title": "Usefulness of amiodarone for the Prevention of new onset Atrial Fibrillation after transcatheter aortic valve implantation: a randomized controlled trial",
    "Start Date": "2019-06-05",
    "Medical condition": "atrial fibrillation",
    "Disease": "Version: 20.0, SOC Term: 10007541 - Cardiac disorders, Classification Code: 10003658, Term: Atrial fibrillation, Level: PT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "ES(Ongoing)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-004202-25"
  },
  {
    "EudraCT Number": "2018-001133-40",
    "Sponsor Protocol Number": "AT1001-025",
    "Sponsor Name": "Amicus Therapeutics, Inc.",
    "Full Title": "An Open-label Study to Evaluate the Safety and Pharmacokinetics of Migalastat HCl in Fabry Subjects with Amenable GLA Variants and Severe Renal Impairment",
    "Start Date": "2020-01-06",
    "Medical condition": "Fabry Subjects with Amenable GLA Variants and Severe Renal Impairment",
    "Disease": "Version: 20.0, SOC Term: 10010331 - Congenital, familial and genetic disorders, Classification Code: 10016016, Term: Fabry's disease, Level: PT",
    "Population Age": "Adolescents, Under 18, Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "GB(GB - no longer in EU/EEA)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-001133-40"
  },
  {
    "EudraCT Number": "2012-003620-20",
    "Sponsor Protocol Number": "P101005",
    "Sponsor Name": "ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)",
    "Full Title": "Tamsulosin to prevent the failures of early bladder catheter removal after acute urinary retention in elderly women hospitalized for an acute medical problem",
    "Start Date": "2013-06-04",
    "Medical condition": "urinary disorder",
    "Disease": "Version: 18.1, SOC Term: 100000004857, Classification Code: 10001055, Term: Acute retention of urine, Level: LLT",
    "Population Age": "Elderly",
    "Gender": "Female",
    "Trial protocol": "FR(Prematurely Ended)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-003620-20"
  },
  {
    "EudraCT Number": "2016-002109-20",
    "Sponsor Protocol Number": "AAV2-hRPE65v2-301",
    "Sponsor Name": "Spark Therapeutics, Inc.",
    "Full Title": "A Safety and Efficacy Study in Subjects with Leber Congenital Amaurosis (LCA) Using Adeno-Associated Viral Vector to Deliver the Gene for Human RPE65 to the Retinal Pigment Epithelium (RPE) [AAV2-h...",
    "Start Date": "2016-10-24",
    "Medical condition": "Leber Congenital Amaurosis (LCA)",
    "Disease": "Version: 19.0, SOC Term: 10010331 - Congenital, familial and genetic disorders, Classification Code: 10070667, Term: Leber's congenital amaurosis, Level: PT",
    "Population Age": "Children, Adolescents, Under 18, Adults",
    "Gender": "Male, Female",
    "Trial protocol": "Outside EU/EEA",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-002109-20"
  },
  {
    "EudraCT Number": "2016-004936-39",
    "Sponsor Protocol Number": "SM2-KHT-2016",
    "Sponsor Name": "Department of Anesthesiology, Næstved Hospital",
    "Full Title": "The influence of different doses of local anaesthetics on the sensory distribution of lateral femoral cutaneous nerve block - a randomised, blinded, paired trial in heathy volunteers",
    "Start Date": "2017-02-01",
    "Medical condition": "Healthy volunteers (treatment intended for pain treatment in patients after hip surgery)",
    "Disease": "Version: 19.1, SOC Term: 100000004863, Classification Code: 10054711, Term: Postoperative pain, Level: LLT",
    "Population Age": "Adults",
    "Gender": "Male, Female",
    "Trial protocol": "DK(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-004936-39"
  },
  {
    "EudraCT Number": "2015-004900-44",
    "Sponsor Protocol Number": "SF114570",
    "Sponsor Name": "GlaxoSmithKline Research & Development",
    "Full Title": "A Multi-center, Randomized, Double-blind, Vehicle-Controlled, Phase 2 Study of the Safety and Efficacy of Benzoyl peroxide/Clindamycin gel and Tazarotene cream when used in combination in the Treat...",
    "Start Date": "2016-12-21",
    "Medical condition": "Acne Vulgaris",
    "Disease": "",
    "Population Age": "Adolescents, Under 18, Adults",
    "Gender": "Male, Female",
    "Trial protocol": "Outside EU/EEA",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-004900-44"
  },
  {
    "EudraCT Number": "2017-004564-35",
    "Sponsor Protocol Number": "205739",
    "Sponsor Name": "GlaxoSmithKline Research and Development Ltd.",
    "Full Title": "A Phase IIa Randomized, Placebo-Controlled, Double-Blind (Sponsor Open) Study to Investigate the Clinical Efficacy, Safety, and Tolerability of Nemiralisib (GSK2269557) in Symptomatic COPD Particip...",
    "Start Date": "2018-08-14",
    "Medical condition": "Chronic Obstructive Pulmonary Disease (COPD)/chronic bronchitis and emphysema",
    "Disease": "Version: 20.0, SOC Term: 100000004855, Classification Code: 10010953, Term: COPD exacerbation, Level: LLT",
    "Population Age": "Adults",
    "Gender": "Male, Female",
    "Trial protocol": "SE(Completed) NL(Prematurely Ended) ES(Prematurely Ended) PL(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-004564-35"
  },
  {
    "EudraCT Number": "2019-002369-36",
    "Sponsor Protocol Number": "GECP19/01",
    "Sponsor Name": "Fundación GECP",
    "Full Title": "Clinical Utility of Liquid Biopsy as a tool to assess the evolution of brigatinib treated patients with non-small cell lung cancer with EML4-ALK translocation: an exploratory study",
    "Start Date": "2020-04-18",
    "Medical condition": "ALK+ non-small cell lung cancer",
    "Disease": "Version: 20.0, SOC Term: 100000004864, Classification Code: 10025055, Term: Lung cancer non-small cell stage IV, Level: LLT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "ES(Ongoing)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-002369-36"
  },
  {
    "EudraCT Number": "2016-001411-20",
    "Sponsor Protocol Number": "CQCC374X2201E1",
    "Sponsor Name": "Novartis Pharma AG",
    "Full Title": "Long-term, open label, multicenter, extension study to evaluate the safety and tolerability of QCC374 in patients with PAH",
    "Start Date": "2018-01-12",
    "Medical condition": "Pulmonary arterial hypertension",
    "Disease": "Version: 20.0, SOC Term: 10038738 - Respiratory, thoracic and mediastinal disorders, Classification Code: 10064911, Term: Pulmonary arterial hypertension, Level: PT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "GB(Prematurely Ended) DE(Prematurely Ended)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001411-20"
  },
  {
    "EudraCT Number": "2017-000263-32",
    "Sponsor Protocol Number": "V260-028",
    "Sponsor Name": "Merck & Co., Inc.",
    "Full Title": "A Double-Blind, Randomized, Placebo-Controlled, Safety and Tolerability Study of Live Pentavalent Human-Bovine Rotavirus Reassortant Vaccine in Chinese Healthy Adults, Children and Infants",
    "Start Date": "2017-03-07",
    "Medical condition": "Prevention of Rotavirus Gastroenteritis Caused by Serotypes G1, G2, G3, G4, and G-Serotypes Associated With P1A [8] (e.g., G9) in Infants",
    "Disease": "Version: 19.1, SOC Term: 100000004862, Classification Code: 10039232, Term: Rotavirus gastroenteritis, Level: LLT",
    "Population Age": "Infants and toddlers, Children, Under 18, Adults",
    "Gender": "Male, Female",
    "Trial protocol": "Outside EU/EEA",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000263-32"
  },
  {
    "EudraCT Number": "2017-002410-31",
    "Sponsor Protocol Number": "GEINO-1602",
    "Sponsor Name": "Grupo Español de Investigación en Neurooncología (GEINO)",
    "Full Title": "Phase Ib/II Multicentric Study Combining Glasdegib with temozolomide in patients with newly diagnosed Glioblastoma, safety and preliminary efficacy for the combination.",
    "Start Date": "2018-02-06",
    "Medical condition": "Glasdegib (SHH pathway inhibitor) is a rational therapeutic agent for patients with newly diagnosed Glioblastoma since inhibits SHH pathway interfering with cancer stem cells and endothelial migrat...",
    "Disease": "Version: 20.0, SOC Term: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps), Classification Code: 10018336, Term: Glioblastoma, Level: PT",
    "Population Age": "Adults",
    "Gender": "Male, Female",
    "Trial protocol": "ES(Ongoing)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-002410-31"
  },
  {
    "EudraCT Number": "2017-003008-30",
    "Sponsor Protocol Number": "16/0730",
    "Sponsor Name": "University College London",
    "Full Title": "A double-blind, randomised, placebo-controlled single-site study of high dose simvastatin treatment for secondary progressive multiple sclerosis: impact on vascular perfusion and oxidative damage",
    "Start Date": "2020-07-01",
    "Medical condition": "Multiple Sclerosis (Secondary Progressive)",
    "Disease": "Version: 20.0, SOC Term: 100000004852, Classification Code: 10052785, Term: Multiple sclerosis acute and progressive, Level: HLT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "GB(GB - no longer in EU/EEA)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-003008-30"
  },
  {
    "EudraCT Number": "2015-003943-20",
    "Sponsor Protocol Number": "DX-2930-03",
    "Sponsor Name": "Dyax Corp., an indirect, wholly-owned subsidiary of Shire plc.",
    "Full Title": "HELP Study™: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate DX 2930 For Long-Term Prophylaxis Against Acute Attacks of Hereditary Angioedema (HAE)",
    "Start Date": "2016-03-31",
    "Medical condition": "Hereditary angioedema (HAE)",
    "Disease": "Version: 19.1, SOC Term: 100000004850, Classification Code: 10075280, Term: Hereditary angioedema attack, Level: LLT",
    "Population Age": "Adolescents, Under 18, Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "DE(Completed) GB(Completed) IT(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-003943-20"
  },
  {
    "EudraCT Number": "2015-004429-15",
    "Sponsor Protocol Number": "GEM-1402",
    "Sponsor Name": "GRUPO ESPAÑOL MULTICISPLINAR DE MELANOMA",
    "Full Title": "Phase II multicente, non randomized, open label trial of nivolumab in combination with ipilimumab in subjects with previously untreated metastatic uveal melanoma.",
    "Start Date": "2016-02-16",
    "Medical condition": "Metastatic uveal melanoma non suitable for radical resection.",
    "Disease": "Version: 18.1, SOC Term: 100000004864, Classification Code: 10053571, Term: Melanoma, Level: LLT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "ES(Ongoing)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-004429-15"
  },
  {
    "EudraCT Number": "2015-002061-29",
    "Sponsor Protocol Number": "08227",
    "Sponsor Name": "Consorci Sanitari de Terrassa",
    "Full Title": "Prospective randomized clinical trial comparing the effect of vaginal misoprostol synchronously with supracervical ball, versus only vaginal misoprostol for induction of labor.",
    "Start Date": "2016-03-21",
    "Medical condition": "Pegnant women with a term singleton pregnancy, cephalic presentation, reassuring fetal heart rate pattern, intact membranes and an unfavorable cervix (Bishop score less than 6), admitted to our ins...",
    "Disease": "Version: 18.1, SOC Term: 100000004865, Classification Code: 10055563, Term: Labor induction, Level: LLT",
    "Population Age": "Adults",
    "Gender": "Female",
    "Trial protocol": "ES(Ongoing)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-002061-29"
  },
  {
    "EudraCT Number": "2016-000238-23",
    "Sponsor Protocol Number": "ExeBAT01",
    "Sponsor Name": "Leiden University Medical Center",
    "Full Title": "The effect of Exenatide on brown adipose tissue activity and energy expenditure in healthy young men",
    "Start Date": "2016-08-09",
    "Medical condition": "Healthy volunteers, intended indications: obesity and dyslipidemia",
    "Disease": "",
    "Population Age": "Adults",
    "Gender": "Male",
    "Trial protocol": "NL(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-000238-23"
  },
  {
    "EudraCT Number": "2017-002849-30",
    "Sponsor Protocol Number": "CCTL019B2101J/CHP-959",
    "Sponsor Name": "University of Pennsylvania",
    "Full Title": "A Phase I/IIA Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCRzeta and 4-1BB Signaling Domains in Patients With Chemotherapy Resistant Or Refractory CD19+ Leuk...",
    "Start Date": "2017-11-16",
    "Medical condition": "Chemotherapy resistant or refractory CD19+ B-cell Leukemia and Lymphoma.",
    "Disease": "Version: 20.0, SOC Term: 10005329 - Blood and lymphatic system disorders, Classification Code: 10025320, Term: Lymphomas non-Hodgkin's B-cell, Level: HLGT",
    "Population Age": "Infants and toddlers, Children, Adolescents, Under 18, Adults",
    "Gender": "Male, Female",
    "Trial protocol": "Outside EU/EEA",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-002849-30"
  },
  {
    "EudraCT Number": "2015-003625-34",
    "Sponsor Protocol Number": "1311.5",
    "Sponsor Name": "Boehringer Ingelheim Finland Ky",
    "Full Title": "A randomised, double-blind, placebo-controlled, proof-of-concept, dose-ranging study of BI 655066 / ABBV-066 / risankiumab in patients with active psoriatic arthritis",
    "Start Date": "2016-04-13",
    "Medical condition": "Active Psoriatic Arthritis",
    "Disease": "Version: 19.0, SOC Term: 100000004859, Classification Code: 10037160, Term: Psoriatic arthritis, Level: LLT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "FI(Completed) ES(Completed) NL(Completed) DE(Completed) BE(Completed) CZ(Completed) FR(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-003625-34"
  },
  {
    "EudraCT Number": "2016-002112-41",
    "Sponsor Protocol Number": "2016-05-04",
    "Sponsor Name": "Region Östergötland",
    "Full Title": "Can Insuline improve the healing of dental implants?",
    "Start Date": "2016-07-16",
    "Medical condition": "Missing teeth",
    "Disease": "",
    "Population Age": "Adults",
    "Gender": "Male, Female",
    "Trial protocol": "SE(Ongoing)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-002112-41"
  },
  {
    "EudraCT Number": "2016-001264-11",
    "Sponsor Protocol Number": "UMCM-2016EPI05",
    "Sponsor Name": "University Medical Center of the Johannes Gutenberg-University Mainz",
    "Full Title": "A phase IV, single-center, randomized, double-blind, placebo-controlled, parallel group study on the effects of empagliflozin on left ventricular diastolic function compared to usual care in indivi...",
    "Start Date": "2016-09-07",
    "Medical condition": "Poorly controlled type 2 diabetes mellitus in adults",
    "Disease": "",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "DE(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001264-11"
  },
  {
    "EudraCT Number": "2016-003937-62",
    "Sponsor Protocol Number": "CLR_16_23",
    "Sponsor Name": "SUN Pharma Global FZE",
    "Full Title": "A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Phase 2b Study to Demonstrate the Safety and Efficacy of Tildrakizumab in Subjects with Active Psoriatic Arthritis",
    "Start Date": "2017-03-20",
    "Medical condition": "Psoriatic Arthritis",
    "Disease": "Version: 20.0, SOC Term:  100000018188, Classification Code: 10037160, Term: Psoriatic arthritis, Level: LLT",
    "Population Age": "Adults",
    "Gender": "Male, Female",
    "Trial protocol": "HU(Completed) ES(Completed) PL(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-003937-62"
  },
  {
    "EudraCT Number": "2016-005111-40",
    "Sponsor Protocol Number": "CN138-178",
    "Sponsor Name": "Otsuka Pharmaceutical Development & Commercialization, Inc",
    "Full Title": "A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Flexible- Dosed Parallel-Group Study of Aripiprazole Flexibly Dosed in the Treatment of Children and Adolescents with Autistic Disorder",
    "Start Date": "2017-04-07",
    "Medical condition": "Autistic Disorder",
    "Disease": "",
    "Population Age": "Children, Adolescents, Under 18",
    "Gender": "Male, Female",
    "Trial protocol": "Outside EU/EEA",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-005111-40"
  },
  {
    "EudraCT Number": "2017-000611-17",
    "Sponsor Protocol Number": "LTS12745",
    "Sponsor Name": "Alfresa Pharma Corporation and Sanofi KK",
    "Full Title": "A Long term study of M071754 - A open-label study in patients with infantile spasms.",
    "Start Date": "2017-08-28",
    "Medical condition": "Patients diagnosed with infantile spasms",
    "Disease": "Version: 20.0, SOC Term: 10029205 - Nervous system disorders, Classification Code: 10021750, Term: Infantile spasms, Level: PT",
    "Population Age": "Infants and toddlers, Children, Under 18",
    "Gender": "Male, Female",
    "Trial protocol": "Outside EU/EEA",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000611-17"
  },
  {
    "EudraCT Number": "2019-000608-14",
    "Sponsor Protocol Number": "1.0/170119",
    "Sponsor Name": "Tartu University Hospital",
    "Full Title": "Prospective validation of individualized Bayesian dose optimization tool DosOpt for Vancomycin treatment in neonates.",
    "Start Date": "Information not available in EudraCT",
    "Medical condition": "In neonatal population wide inter-and intra-individual variability of pharmacokinetics makes extremely difficult to ensure optimal exposure of vancomycin with standard regimens. On average >50% of ...",
    "Disease": "",
    "Population Age": "Preterm newborn infants, Newborns, Under 18",
    "Gender": "Male, Female",
    "Trial protocol": "EE(Ongoing)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-000608-14"
  },
  {
    "EudraCT Number": "2016-000608-27",
    "Sponsor Protocol Number": "ProtokolSB2",
    "Sponsor Name": "Aarhus University Hospital",
    "Full Title": "The effect of subsartorial saphenous block on postoperative pain following major ankle and hind foot surgery",
    "Start Date": "2016-04-05",
    "Medical condition": "Post-operative pain after four types of major ankle and hind foot surgery:",
    "Disease": "Version: 19.0, SOC Term: 100000004865, Classification Code: 10002540, Term: Ankle arthrodesis, Level: LLT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "DK(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-000608-27"
  },
  {
    "EudraCT Number": "2014-003833-24",
    "Sponsor Protocol Number": "AGMT_HNO_PN",
    "Sponsor Name": "AGMT – Arbeitsgemeinschaft medikamentöse Tumortherapie gemeinnützige GmbH",
    "Full Title": "Randomized phase III study: Supplemental parenteral nutrition for patients with locally advanced inoperable tumors of the head and neck, receiving definitive radiotherapy with Cetuximab or Cisplatin",
    "Start Date": "2016-06-30",
    "Medical condition": "Locally advanced inoperable tumors of the head and neck under definitive radiotherapy with Cetuximab or Cisplatin",
    "Disease": "Version: 20.0, SOC Term: 100000004864, Classification Code: 10023861, Term: Laryngeal squamous cell carcinoma stage IV, Level: LLT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "AT(Prematurely Ended)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2014-003833-24"
  },
  {
    "EudraCT Number": "2016-000473-20",
    "Sponsor Protocol Number": "CLCZ696B3402",
    "Sponsor Name": "Novartis Pharma services AG",
    "Full Title": "A prospective evaluation of natriuretic peptide based referral of CHF patients in primary care",
    "Start Date": "2016-08-18",
    "Medical condition": "Chronic heart failure with reduced ejection fraction",
    "Disease": "Version: 19.0, SOC Term: 100000004849, Classification Code: 10019279, Term: Heart failure, Level: LLT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "HR(Prematurely Ended)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-000473-20"
  },
  {
    "EudraCT Number": "2017-003629-13",
    "Sponsor Protocol Number": "PROFIT",
    "Sponsor Name": "King's College London",
    "Full Title": "A Prospective, randomised placebo controlled feasibility trial of Faecal Microbiotica Transplantation in cirrhosis",
    "Start Date": "2018-01-31",
    "Medical condition": "Cirrhosis of the liver",
    "Disease": "Version: 20.0, SOC Term: 100000004871, Classification Code: 10024667, Term: Liver cirrhosis, Level: LLT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "GB(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-003629-13"
  },
  {
    "EudraCT Number": "2019-001974-27",
    "Sponsor Protocol Number": "STOPFLU",
    "Sponsor Name": "Centre Hospitalier Universitaire Vaudois (CHUV)",
    "Full Title": "Reducing the Burden of Influenza after Solid-Organ Transplantation: the STOP-FLU trial [Swiss Trial in solid Organ transplantation on Prevention of inFLUenza]",
    "Start Date": "2019-10-15",
    "Medical condition": "Influenza in solid organ transplant patients",
    "Disease": "Version: 21.1, SOC Term: 10042613 - Surgical and medical procedures, Classification Code: 10059429, Term: Influenza immunisation, Level: PT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "ES(Ongoing)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-001974-27"
  },
  {
    "EudraCT Number": "2019-002956-18",
    "Sponsor Protocol Number": "ZWI-ZW25-202",
    "Sponsor Name": "Zymeworks Inc.",
    "Full Title": "Phase 2a Study of ZW25 in Combination with Palbociclib Plus Fulvestrant",
    "Start Date": "2020-03-25",
    "Medical condition": "Breast cancer  patients including those with locally advanced (unresectable) or metastatic HER2-positive, HR-positive breast cancer.",
    "Disease": "",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "ES(Ongoing)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-002956-18"
  },
  {
    "EudraCT Number": "2016-001586-87",
    "Sponsor Protocol Number": "RSLV-132-04",
    "Sponsor Name": "Resolve Therapeutics, LLC",
    "Full Title": "A Phase 2, Double Blind, Placebo Controlled Study of RSLV-132 in Subjects with Primary Sjogren’s Syndrome",
    "Start Date": "2016-09-29",
    "Medical condition": "Primary Sjogrens Syndrome",
    "Disease": "",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "GB(Completed)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-001586-87"
  },
  {
    "EudraCT Number": "2016-003248-34",
    "Sponsor Protocol Number": "IMPAACTP1110",
    "Sponsor Name": "NIAID and NICHD",
    "Full Title": "A PHASE I TRIAL TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF RALTEGRAVIR IN HIV-1-EXPOSED NEONATES AT HIGH RISK OF ACQUIRING HIV-1 INFECTION",
    "Start Date": "2016-11-02",
    "Medical condition": "New born babies at risk of acquiring HIV from their infected mothers.",
    "Disease": "Version: 20.1, SOC Term: 100000004862, Classification Code: 10053529, Term: Vertical human immunodeficiency virus transmission, Level: LLT",
    "Population Age": "Newborns, Under 18",
    "Gender": "Male, Female",
    "Trial protocol": "Outside EU/EEA",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2016-003248-34"
  },
  {
    "EudraCT Number": "2017-000755-97",
    "Sponsor Protocol Number": "EPFL-CNBI-2017-01",
    "Sponsor Name": "Defitech Chair in Brain-Machine Interface, EPFL",
    "Full Title": "Brain-computer interface and neuromuscular stimulation for rehabilitation following chronic stroke",
    "Start Date": "2017-03-16",
    "Medical condition": "I61 - Intracerebral haemorrhage",
    "Disease": "",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "Outside EU/EEA",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-000755-97"
  },
  {
    "EudraCT Number": "2017-004903-33",
    "Sponsor Protocol Number": "IBM4809",
    "Sponsor Name": "Orphazyme A/S",
    "Full Title": "Phase 2/3 Study of Arimoclomol in Inclusion Body Myositis (IBM) A Randomized, Double-blind, Placebo-Controlled Trial",
    "Start Date": "2018-06-18",
    "Medical condition": "Sporadic Inclusion Body Myositis (sIBM)",
    "Disease": "Version: 21.1, SOC Term: 100000004859, Classification Code: 10075052, Term: Sporadic inclusion body myositis, Level: LLT",
    "Population Age": "Adults, Elderly",
    "Gender": "Male, Female",
    "Trial protocol": "GB(GB - no longer in EU/EEA)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-004903-33"
  },
  {
    "EudraCT Number": "2019-003486-17",
    "Sponsor Protocol Number": "9-VPH-MVIH",
    "Sponsor Name": "CARMEN HIDALGO TENORIO",
    "Full Title": "Immunogenicity and safety of a 9-valent human papillomavirus vaccine in HIV-positive women",
    "Start Date": "2020-02-11",
    "Medical condition": "New infection and lesions of papillomavirus in HIV-infected women",
    "Disease": "",
    "Population Age": "Adults",
    "Gender": "Female",
    "Trial protocol": "ES(Ongoing)",
    "Link": "https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-003486-17"
  }
]
export default EudraCTData